JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI), and a companion title to the field-leading The Journal of Allergy and Clinical Immunology. It brings timely clinical papers, instructive case reports, and the latest management recommendations to clinical allergists and other physicians concerned with clinical manifestations of allergic and immunologic diseases in their practice.

Metrics

• Mean days from submission to first decision: 11.1

• Mean days from acceptance to online publication 6

• Clarivate Impact Factor 8.861, ranking 3rd out of 28 journals in the Allergy category and 19th out of 162 journals in the Immunology category

Vision

The vision of JACI: In Practice is to be an indispensable resource for clinicians who manage patients with asthma, allergic, immunologic, and related conditions in order to optimize the care and health of these patients.

Mission

The mission of JACI: In Practice is to provide novel, valid, generalizable, and impactful information to support evidence-based clinical decisions in the diagnosis and management of asthma, allergic, immunologic, and related conditions.

AAAAI Journals Diversity Statement

Equity and inclusion in publishing are critically important for scientific innovation and excellence. The AAAAI Journals value inclusion and diversity across research, through its various lenses, be it authors, reviewers, or editors. This is in line with the AAAAI Diversity Equity and Inclusion Statement as well as Elsevier’s support of the joint commitment for action on inclusion and diversity in publishing. We are committed to multilevel initiatives to promote diversity, equity, and inclusion in the articles we publish and in the people who write, review, and edit them.

Scope

JACI: In Practice publishes clinically impactful articles on the spectrum of conditions treated by allergist-immunologists in their practice: food allergy, respiratory disorders (including asthma, allergic and nonallergic rhinitis/rhinoconjunctivitis, nasal polyps, chronic sinusitis, cough, allergic bronchopulmonary aspergillosis [ABPA], and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (including atopic dermatitis, contact dermatitis, urticaria, angioedema, and hereditary angioedema [HAE]), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders. The Journal emphasizes cutting edge practical clinical information for practitioners that they can use in everyday practice or will help them acquire new knowledge or skills they can directly apply to patient care. Mechanistic or translational studies without immediate or near future clinical relevance and animal studies are not within the scope of the Journal.